Form 4: Femasys Director Charles Larsen Granted 17,600 Stock Options

Femasys Inc. Director Charles Larsen has been granted stock options to acquire 17,600 shares of common stock at an exercise price of $0.98 per share, vesting one year from the grant date.

Summary

• Charles Larsen, a Director of Femasys Inc. (FEMY), was granted 17,600 stock options.
• The options have an exercise price of $0.98 per share.
• The grant date for these options was June 25, 2025.
• The options will become exercisable one year from the grant date, specifically on June 25, 2026, assuming continued service.
• The expiration date for these stock options is June 25, 2035.
• The options were acquired under transaction code 'A', indicating an acquisition.
• Following this transaction, Charles Larsen beneficially owns 17,600 derivative securities directly.

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally a positive signal, indicating alignment of interests and confidence in future performance, though the size of the grant is not exceptionally large to be highly price-sensitive.

Positives

• The grant of stock options to a director aligns management's interests with those of shareholders, as the options gain value if the company's stock price increases.
• The exercise price of $0.98 suggests a belief in future stock price appreciation above this level.

Future Outlook

The stock options are subject to a one-year vesting period from the grant date, contingent upon Charles Larsen's continued service to the company, indicating a future incentive for continued engagement.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity compensation grant to a director. It does not provide broader industry context but is a common practice in publicly traded companies to incentivize and retain key personnel.

Related Party Transactions

• The grant of stock options to Director Charles Larsen constitutes a related party transaction, as it involves compensation from the company to a member of its board.

Stakeholder Impact

• Shareholders: The grant aligns the director's financial interests with those of shareholders, potentially encouraging decisions that enhance shareholder value.
• Employees (specifically Charles Larsen): Provides an incentive for continued service and performance, with potential for personal financial gain if the company's stock price increases.

Next Steps

• The stock options will vest on June 25, 2026, assuming Charles Larsen's continued service.

Key Dates

Keywords

Femasys Inc., FEMY, Stock Option Grant, Director Compensation, Insider Transaction, SEC Form 4, Beneficial Ownership, Equity Compensation